Please use this identifier to cite or link to this item:
http://dspace.nuph.edu.ua/handle/123456789/37192| Title: | Rationale for the development of combined analgesics in softgel capsule form |
| Authors: | Kravchenko, Y. I. Sichkar, A. A. |
| Issue Date: | 2026 |
| Publisher: | НФаУ |
| Bibliographic description (Ukraine): | Kravchenko Y. I. Rationale for the development of combined analgesics in softgel capsule form / Y. I. Kravchenko, A. A. Sichkar // Фармацевтичні технології, стандартизація та забезпечення якості лікарських засобів : матеріали ІІІ Internet-конф. з міжнар. участю, м. Харків, 16 черв. 2026 р. / редкол.: О. С. Кухтенко [та ін.]. – Харків : НФаУ, 2026. – С. 6. |
| Abstract: | Introduction. An analysis of the Ukrainian pharmaceutical market for 2023– 2025 shows a growth in sales of medicines in group N02 (analgesics), which rank second according to the ATC classification. This group of medicines consistently holds the second position in terms of pharmacy sales in Ukraine. This justifies the relevance of developing combined analgesics in soft capsules, which have a rapid onset of action and improved gastrointestinal tolerability. |
| URI: | http://dspace.nuph.edu.ua/handle/123456789/37192 |
| Appears in Collections: | Тези доповідей співробітників НФаУ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Зб. мат конф. ФТСЗЯЛЗ 6.pdf | 410,61 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.